Familial thoracic aortic aneurysm and aortic dissection: genes and variants
Explore variant evidence for Familial thoracic aortic aneurysm and aortic dissection across 20 analyzed proteins (FBN1, TGFBR2, COL3A1, SMAD3, TGFBR1 and 15 more). Linked ClinVar records include 645 pathogenic or likely pathogenic variants, 6,153 variants of uncertain significance and 1,324 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial thoracic aortic aneurysm and aortic dissection
FBN1: Fibrillin-1
Its fibrillin-1 microfibrils provide mechanical support to elastic tissues and regulate local availability of growth factors such as TGF-beta. Pathogenic variants cause Marfan syndrome and related fibrillinopathies affecting the aorta, skeleton, eyes, skin, and lungs.
406 ClinVar pathogenic / likely pathogenic and 1,199 uncertain variants in FBN1 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
TGFBR2: TGF-beta receptor type-2
It binds TGF-beta ligands and activates TGFBR1 to initiate canonical and noncanonical signaling. Germline pathogenic variants cause Loeys-Dietz syndrome type 2, while somatic loss can remove growth-suppressive TGF-beta responses in cancer.
78 ClinVar pathogenic / likely pathogenic and 452 uncertain variants in TGFBR2 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
COL3A1: Collagen alpha-1(III) chain
Its type III collagen fibrils provide tensile support in arteries, bowel, uterus, skin, and other distensible connective tissues. Pathogenic variants cause vascular Ehlers-Danlos syndrome with marked arterial and hollow-organ fragility.
57 ClinVar pathogenic / likely pathogenic and 528 uncertain variants in COL3A1 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
SMAD3: SMAD family member 3
It carries TGF-beta receptor signals into the nucleus to control extracellular-matrix, differentiation, and growth programs. Heterozygous loss-of-function variants cause Loeys-Dietz syndrome type 3 with arterial aneurysm and dissection risk and often early osteoarthritis.
29 ClinVar pathogenic / likely pathogenic and 306 uncertain variants in SMAD3 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
TGFBR1: TGF-beta receptor type-1
After activation by the ligand-bound receptor complex, it phosphorylates SMAD2 and SMAD3 to propagate TGF-beta signals. Germline pathogenic variants cause Loeys-Dietz syndrome type 1 with arterial aneurysm and dissection and variable craniofacial or skeletal features.
23 ClinVar pathogenic / likely pathogenic and 356 uncertain variants in TGFBR1 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
SMAD4: SMAD family member 4
It forms transcriptional complexes with activated receptor-regulated SMADs and is the central nuclear mediator shared by TGF-beta and BMP pathways. Germline loss-of-function variants cause juvenile polyposis or combined juvenile-polyposis-HHT, while specific gain-of-function variants cause Myhre syndrome.
12 ClinVar pathogenic / likely pathogenic and 502 uncertain variants in SMAD4 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
ACTA2: Actin, aortic smooth muscle
Its smooth-muscle actin filaments generate contractile force in arteries and visceral organs and help maintain vascular-wall structure. Pathogenic variants are an important cause of familial thoracic aortic aneurysm and dissection and can also produce occlusive vascular disease.
9 ClinVar pathogenic / likely pathogenic and 139 uncertain variants in ACTA2 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
CBS: Cystathionine beta-synthase
A vitamin B6-dependent enzyme that combines homocysteine and serine to form cystathionine in the transsulfuration pathway. Deficiency causes homocystinuria.
9 ClinVar pathogenic / likely pathogenic and 117 uncertain variants in CBS have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
SLC2A10: Solute carrier family 2, facilitated glucose transporter member 10
GLUT10, a transporter implicated in the intracellular movement of dehydroascorbic acid, an oxidized form of vitamin C. It helps maintain vascular connective tissues, and biallelic loss-of-function variants cause arterial tortuosity syndrome.
5 ClinVar pathogenic / likely pathogenic and 165 uncertain variants in SLC2A10 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
TGFB2: Transforming growth factor beta-2 proprotein
Its secreted signaling regulates extracellular matrix, cell differentiation, proliferation, and cardiovascular development. Haploinsufficiency causes a Loeys-Dietz-spectrum connective-tissue disorder with increased risk of thoracic aortic aneurysm and dissection.
5 ClinVar pathogenic / likely pathogenic and 115 uncertain variants in TGFB2 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
COL5A1: Collagen alpha-1(V) chain
It helps nucleate and regulate type I collagen fibril assembly, controlling fibril diameter and connective-tissue architecture. Haploinsufficiency or structural variants are a major cause of classical Ehlers-Danlos syndrome, with skin hyperextensibility, atrophic scarring, and joint hypermobility.
3 ClinVar pathogenic / likely pathogenic and 293 uncertain variants in COL5A1 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
MYH11: Myosin-11
Its smooth-muscle myosin motor generates contractile force in arteries and visceral organs. Pathogenic variants can impair aortic smooth-muscle mechanics and cause familial thoracic aortic aneurysm and dissection, sometimes with patent ductus arteriosus.
2 ClinVar pathogenic / likely pathogenic and 1,256 uncertain variants in MYH11 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
NOTCH1: Neurogenic locus notch homolog protein 1
Ligand-dependent cleavage releases an intracellular domain that directly controls transcriptional programs governing cell fate and differentiation. Pathogenic variants can cause congenital aortic-valve disease and left-sided heart defects, while activating or inactivating somatic changes contribute to several cancers.
2 ClinVar pathogenic / likely pathogenic and 863 uncertain variants in NOTCH1 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
FLNA: Filamin-A
It crosslinks actin and connects the cytoskeleton to membrane receptors and signaling proteins during cell migration and tissue morphogenesis. Pathogenic variants cause a broad spectrum including periventricular nodular heterotopia and several skeletal or connective-tissue disorders.
2 ClinVar pathogenic / likely pathogenic and 160 uncertain variants in FLNA have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
MYLK: Myosin light chain kinase, smooth muscle
It phosphorylates myosin regulatory light chains to initiate smooth-muscle contraction in blood vessels and visceral tissues. Pathogenic loss-of-function variants can reduce arterial contractile integrity and cause familial thoracic aortic aneurysm and dissection.
1 ClinVar pathogenic / likely pathogenic and 682 uncertain variants in MYLK have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
PRKG1: cGMP-dependent protein kinase 1
It transduces cyclic-GMP signals from nitric oxide and natriuretic peptides to promote vascular smooth-muscle relaxation and regulate vascular tone. A recurrent activating variant causes highly penetrant familial thoracic aortic aneurysm and dissection.
1 ClinVar pathogenic / likely pathogenic and 135 uncertain variants in PRKG1 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
LOX: Protein-lysine 6-oxidase
It oxidatively initiates covalent crosslinking of collagen and elastin, strengthening arteries and other extracellular matrices. Pathogenic loss-of-function variants can weaken the aortic wall and predispose to familial thoracic aortic aneurysm and dissection.
1 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in LOX have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
FBN2: Fibrillin-2
It contributes to extracellular microfibrils that guide elastic-fiber formation and tissue organization during development. Heterozygous pathogenic variants cause congenital contractural arachnodactyly, characterized by long limbs and fingers, contractures, and characteristic ear abnormalities.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in FBN2 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
COL5A2: Collagen alpha-2(V) chain
It partners with COL5A1-derived chains to regulate collagen fibril formation in skin, tendons, and other connective tissues. Pathogenic variants can cause classical Ehlers-Danlos syndrome with tissue fragility, hyperextensible skin, and joint hypermobility.
0 ClinVar pathogenic / likely pathogenic and 192 uncertain variants in COL5A2 have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
ELN: Elastin
Its elastic fibers allow arteries, lungs, skin, and other tissues to stretch and recoil repeatedly without structural failure. Haploinsufficiency causes supravalvular aortic stenosis, while other pathogenic variants can cause autosomal dominant cutis laxa.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in ELN have source records linked to Familial thoracic aortic aneurysm and aortic dissection. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): GATA5, KMT2D, MTOR and SMAD2.
Where Familial thoracic aortic aneurysm and aortic dissection variants cluster
- TGFBR2 Protein kinase (positions 244–544): 62 of 62 ClinVar pathogenic / likely pathogenic variants, 1.9× more than its size predicts (a length-based count, not a validated hotspot).
- TGFBR1 Protein kinase (positions 205–495): 22 of 22 ClinVar pathogenic / likely pathogenic variants, 1.7× more than its size predicts (a length-based count, not a validated hotspot).
- SMAD4 MH2 (positions 323–552): 12 of 12 ClinVar pathogenic / likely pathogenic variants, 2.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Familial thoracic aortic aneurysm and aortic dissection
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TGFB2 R299Q | 299 | Pathogenic / likely pathogenic (★★★★) | |
| ACTA2 R39C | 39 | Pathogenic / likely pathogenic (★★) | |
| ACTA2 R258C | 258 | Pathogenic / likely pathogenic (★★) | |
| SMAD3 R268H | 268 | MH2 | Pathogenic / likely pathogenic (★★) |
| SMAD3 R287Q | 287 | MH2 | Pathogenic / likely pathogenic (★★) |
| SMAD3 R287W | 287 | MH2 | Pathogenic / likely pathogenic (★★) |
| SMAD4 R361C | 361 | MH2 | Pathogenic / likely pathogenic (★★) |
| TGFBR1 R487Q | 487 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 L305H | 305 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 C393Y | 393 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 C393R | 393 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 M425V | 425 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R460L | 460 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R460H | 460 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R460C | 460 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R460G | 460 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 Y470D | 470 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R537C | 537 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ACTA2 R39G | 39 | Pathogenic / likely pathogenic (★★) | |
| ACTA2 R39H | 39 | Pathogenic / likely pathogenic (★★) | |
| COL3A1 G435D | 435 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G435S | 435 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| FBN1 C476Y | 476 | EGF-like 6 | Pathogenic / likely pathogenic (★★) |
| FBN1 C494W | 494 | EGF-like 7 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1577Y | 1577 | TB 6 | Pathogenic / likely pathogenic (★★) |
| FBN1 C2258G | 2258 | EGF-like 39 | Pathogenic / likely pathogenic (★★) |
| SMAD3 M1T | 1 | Pathogenic / likely pathogenic (★★) | |
| SMAD3 M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| SMAD3 P263L | 263 | MH2 | Pathogenic / likely pathogenic (★★) |
| TGFBR1 R487W | 487 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 L305F | 305 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R378S | 378 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TGFBR2 R537H | 537 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ACTA2 R149C | 149 | Pathogenic / likely pathogenic (★★) | |
| CBS G148R | 148 | Pathogenic / likely pathogenic (★★) | |
| CBS C165Y | 165 | Pathogenic / likely pathogenic (★★) | |
| CBS R336P | 336 | Pathogenic / likely pathogenic (★★) | |
| CBS G347S | 347 | Pathogenic / likely pathogenic (★★) | |
| COL3A1 G213D | 213 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G342R | 342 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G360D | 360 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G378D | 378 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G588S | 588 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G744C | 744 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G897S | 897 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL3A1 G1056S | 1056 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| FBN1 C358S | 358 | TB 2 | Pathogenic / likely pathogenic (★★) |
| FBN1 C541Y | 541 | EGF-like 8 | Pathogenic / likely pathogenic (★★) |
| FBN1 C582Y | 582 | EGF-like 9 | Pathogenic / likely pathogenic (★★) |
| FBN1 C596Y | 596 | EGF-like 9 | Pathogenic / likely pathogenic (★★) |
| FBN1 C628S | 628 | EGF-like 10 | Pathogenic / likely pathogenic (★★) |
| FBN1 C628Y | 628 | EGF-like 10 | Pathogenic / likely pathogenic (★★) |
| FBN1 C628W | 628 | EGF-like 10 | Pathogenic / likely pathogenic (★★) |
| FBN1 E726G | 726 | EGF-like 11 | Pathogenic / likely pathogenic (★★) |
| FBN1 C830F | 830 | EGF-like 13 | Pathogenic / likely pathogenic (★★) |
| FBN1 C832F | 832 | EGF-like 13 | Pathogenic / likely pathogenic (★★) |
| FBN1 R954L | 954 | Pathogenic / likely pathogenic (★★) | |
| FBN1 C1265Y | 1265 | EGF-like 20 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1491F | 1491 | EGF-like 26 | Pathogenic / likely pathogenic (★★) |
| FBN1 A1728V | 1728 | TB 7 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 645.
Uncertain variants prioritized for review in Familial thoracic aortic aneurysm and aortic dissection
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SMAD3 R243H | 243 | MH2 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; R243C at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.975 |
| COL3A1 G432S | 432 | Triple-helical region | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; G432D at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.974 |
| TGFBR2 H377D | 377 | Protein kinase | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; H377R at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.992 |
| TGFBR2 Y424H | 424 | Protein kinase | Conflicting reports (★) | +7: 6 other pathogenic changes within 3 positions; Y424C at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.959 |
| TGFBR2 C393G | 393 | Protein kinase | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; C393Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.944 |
| TGFBR2 M450I | 450 | Protein kinase | Conflicting reports (★) | +7: 5 other pathogenic changes within 3 positions; M450T at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.798 |
| TGFBR2 L305R | 305 | Protein kinase | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; L305H at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.844 |
| TGFBR2 W504R | 504 | Protein kinase | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; W504C at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.775 |
| TGFBR2 F442L | 442 | Protein kinase | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; F442I at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.835 |
| TGFBR2 K277R | 277 | Protein kinase | Uncertain (★★) | +7: K277N at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.967 |
| COL5A1 G835S | 835 | Triple-helical region | Uncertain (★★) | +7: G835A at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.980 |
| TGFBR2 D524Y | 524 | Protein kinase | Uncertain (★★) | +7: 8 other pathogenic changes within 3 positions; D524N at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.911 |
| TGFBR2 Y470N | 470 | Protein kinase | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; Y470D at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.938 |
| TGFBR2 T530R | 530 | Protein kinase | Uncertain (★) | +7: 5 other pathogenic changes within 3 positions; T530I at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.948 |
| TGFBR2 C393S | 393 | Protein kinase | Uncertain (★) | +7: 5 other pathogenic changes within 3 positions; C393Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.891 |
| SMAD3 T261A | 261 | MH2 | Uncertain (★) | +7: 6 other pathogenic changes within 3 positions; T261I at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.976 |
| ACTA2 R149H | 149 | Uncertain (★★) | +7: in a 3D region that tolerates change poorly (2R); R149C at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.862 | |
| SMAD3 D262N | 262 | MH2 | Uncertain (★★) | +7: 5 other pathogenic changes within 3 positions; D262V at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.835 |
| TGFBR2 S441C | 441 | Protein kinase | Uncertain (★) | +7: 3 other pathogenic changes within 3 positions; S441F at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.847 |
| TGFBR2 S441Y | 441 | Protein kinase | Uncertain (★) | +7: 3 other pathogenic changes within 3 positions; S441F at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.819 |
| SMAD3 P263R | 263 | MH2 | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; P263L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SMAD3 P263S | 263 | MH2 | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; P263L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SMAD3 S423N | 423 | MH2 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; S423I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| TGFBR1 R487L | 487 | Protein kinase | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R487W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| SLC2A10 R105H | 105 | Extracellular | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (1R); R105C at the same position is pathogenic; REVEL 0.922 |
| TGFBR2 M425I | 425 | Protein kinase | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; M425V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SMAD3 P68S | 68 | MH1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P68L at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.676 |
| TGFBR1 R225W | 225 | Protein kinase | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R225G at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.680 |
| SMAD3 D258A | 258 | MH2 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; D258H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SMAD3 D258G | 258 | MH2 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; D258H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SMAD3 V331D | 331 | MH2 | Uncertain (★) | +6: in a 3D region that tolerates change poorly (1R); V331F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| SMAD3 G245E | 245 | MH2 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G245R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| TGFBR1 R487G | 487 | Protein kinase | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; R487W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| SMAD3 S423R | 423 | MH2 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; S423I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| FBN1 D1363V | 1363 | EGF-like 23 | Uncertain (★) | +6: D1363Y at the same position is pathogenic; REVEL 0.979 |
| SMAD3 E284Q | 284 | MH2 | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; E284G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.94 |
| FBN1 L879R | 879 | TB 4 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; L879P at the same position is pathogenic; REVEL 0.920 |
| FBN1 R2220L | 2220 | EGF-like 38 | Uncertain (★★) | +6: 6 other pathogenic changes within 3 positions; R2220P at the same position is pathogenic; REVEL 0.817 |
| SMAD3 V331I | 331 | MH2 | Uncertain (★★) | +6: in a 3D region that tolerates change poorly (1R); V331F at the same position is pathogenic; REVEL 0.773 |
| TGFBR1 V229L | 229 | Protein kinase | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; V229A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
Which prediction tools work for Familial thoracic aortic aneurysm and aortic dissection
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- VARITY: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- MutPred: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- AlphaGenome (regulatory): 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 92 out of 100
- CADD: 90 out of 100
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phastCons: 88 out of 100
- SIFT: 86 out of 100
- phyloP: 76 out of 100
- AlphaGenome (splicing): 58 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 47 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 35 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Isolated thoracic aortic aneurysm also has ClinVar records linked to FBN1 variants; they fall in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (12 pathogenic / likely pathogenic).
- Acromicric dysplasia also has ClinVar records linked to FBN1 variants; they fall partly in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (6 pathogenic / likely pathogenic).
- Ectopia lentis 1, isolated, autosomal dominant also has ClinVar records linked to FBN1 variants; they fall in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (6 pathogenic / likely pathogenic).
- Geleophysic dysplasia also has ClinVar records linked to FBN1 variants; they fall partly in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (6 pathogenic / likely pathogenic).
- Stiff skin syndrome also has ClinVar records linked to FBN1 variants; they fall in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (3 pathogenic / likely pathogenic).
- Loeys-Dietz syndrome also has ClinVar records linked to TGFBR2 variants; they fall in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (49 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome also has ClinVar records linked to TGFBR2 variants; they fall in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (4 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome also has ClinVar records linked to COL3A1 variants; they fall partly in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (196 pathogenic / likely pathogenic).
- Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome also has ClinVar records linked to COL3A1 variants; they fall mostly in different places as the Familial thoracic aortic aneurysm and aortic dissection variants (6 pathogenic / likely pathogenic).
- Familial aortopathy also has ClinVar records linked to COL3A1 variants; they fall mostly in different places as the Familial thoracic aortic aneurysm and aortic dissection variants (5 pathogenic / likely pathogenic).
- Aneurysm-osteoarthritis syndrome also has ClinVar records linked to SMAD3 variants; they fall partly in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (18 pathogenic / likely pathogenic).
- Loeys-Dietz syndrome also has ClinVar records linked to TGFBR1 variants; they fall partly in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (23 pathogenic / likely pathogenic).
- Polyposis also has ClinVar records linked to SMAD4 variants; they fall in the same places as the Familial thoracic aortic aneurysm and aortic dissection variants (18 pathogenic / likely pathogenic).
Diseases related to Familial thoracic aortic aneurysm and aortic dissection
- Connective tissue disease, also linked to CBS, COL3A1, COL5A1, COL5A2 and 6 more
- Ehlers-Danlos syndrome, also linked to COL3A1, COL5A1, COL5A2, SMAD3 and 3 more
- Aortic aneurysm, familial thoracic, also linked to ACTA2, LOX, MYH11, MYLK and 1 more
- Familial aortopathy, also linked to ACTA2, COL3A1, FBN1, SLC2A10 and 1 more
- Loeys-Dietz syndrome, also linked to SMAD3, TGFB2, TGFBR1 and TGFBR2
- Marfan syndrome, also linked to FBN1, TGFBR1 and TGFBR2
- Isolated thoracic aortic aneurysm, also linked to ACTA2, FBN1 and MYH11
- Ehlers-Danlos syndrome, classic, also linked to COL5A1 and COL5A2
- Marfan syndrome/loeys-dietz syndrome/familial thoracic aortic aneurysms and dissections, also linked to FBN1 and LOX
- Familial hemophagocytic lymphohistiocytosis, also linked to COL3A1 and SLC2A10
- Cutis laxa, also linked to ELN and LOX
- Esophageal cancer, also linked to SMAD4 and TGFBR2
Frequently asked questions
Which genes have records linked to Familial thoracic aortic aneurysm and aortic dissection?
This view contains 20 analyzed proteins: FBN1, TGFBR2, COL3A1, SMAD3, TGFBR1 and 15 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 645 pathogenic or likely pathogenic variants, 6,153 variants of uncertain significance and 1,324 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 46 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 8,672 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center